Updated: Lundbeck makes $2.6B cash move for Longboard a month after starting Phase 3 in Dravet syndrome

Dan­ish drug­mak­er Lund­beck will buy La Jol­la, CA-based Long­board Phar­ma­ceu­ti­cals for $2.6 bil­lion in cash, the com­pa­nies said Mon­day morn­ing, mark­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.